NIMBLE ONCOLOGY
Dead / Cancelled — Cancelled — Section 8 (as of 09 Aug 2024)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87173202
- Registration number
- 5389256
- Mark type
- Stylized text
- Filed
- 16 Sept 2016
- Published for opposition
- 15 Aug 2017
- Registered
- 30 Jan 2018
- Attorney of record
- Clark A.D. Wilson
Goods and services
- Class 042 — Scientific and technological services: Consulting services in the fields of oncology, pharmaceutical research and development, laboratory testing, and diagnostics
Owner
- BOSTON BIOPHARMA HOLDING, LLC, ALPHARETTA, GA, US
- Boston Biopharma, Inc, Alpharetta, GA, US
- Boston Biopharma, Inc, Alpharetta, GA, US
- Boston Biopharma, Inc, Alpharetta, GA, US
Prosecution history
- 09 Aug 2024 — CANCELLED SEC. 8 (6-YR)
- 30 Jan 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 14 Feb 2018 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 01 Feb 2018 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 01 Feb 2018 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 30 Jan 2018 — REGISTERED-PRINCIPAL REGISTER
- 24 Dec 2017 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 13 Sept 2017 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 15 Aug 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Aug 2017 — PUBLISHED FOR OPPOSITION
- 26 Jul 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Jul 2017 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Jul 2017 — EXAMINER'S AMENDMENT ENTERED
- 06 Jul 2017 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 06 Jul 2017 — EXAMINERS AMENDMENT E-MAILED